-

05:05:23 PM

AEMD Stock News

AEMD - Aethlon Medical Inc

09/06/22 8:01 AM

Nasdaq : AEMD

conferences

Aethlon Medical to Present at Two Investor Conferences in September

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life-threatening infectious diseases, today announced that it will be presenting at two investor conferences in September.

RHEA-AI

neutral

08/09/22 4:15 PM

Nasdaq : AEMD

earnings

Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today reported financial results for its first quarter ended June 30, 2022 and provided

RHEA-AI

neutral

08/03/22 12:47 PM

Nasdaq : AEMD

earnings

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2022

Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its first quarter ended June 30, 2022, at 4:15 p.m. EST on

RHEA-AI

neutral

07/28/22 2:01 PM

Nasdaq : AEMD

covid-19

Aethlon Medical Announces Publication of Peer-Reviewed Journal Article Describing Hemopurifier Resin Binding of Seven COVID-19 Variants

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today announced the publication of a peer-reviewed journal article in PLOS ONE. The

RHEA-AI

neutral

07/11/22 8:01 AM

Nasdaq : AEMD

fda approvalcovid-19

Aethlon Medical Announces U.S. FDA Approval of Hemopurifier COVID-19 Study Protocol Amendment

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and

RHEA-AI

neutral

06/28/22 4:15 PM

Nasdaq : AEMD

earnings

Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening infectious diseases, today reported financial results for its fiscal year ended March 31, 2022 and provided an

RHEA-AI

neutral

06/21/22 8:01 AM

Nasdaq : AEMD

earnings

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 28, 2022

Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its fiscal year ended March 31, 2022, at 4:15 p.m. EST on

RHEA-AI

neutral

05/24/22 4:21 PM

Nasdaq : AEMD

/C O R R E C T I O N -- Aethlon Medical, Inc./

In the news release, Aethlon Medical to Present at the H.C. Wainwright Global Investment Conference, issued 17-May-2022 by Aethlon Medical, Inc. over PR Newswire, we are advised by the company that in the "Company Webcasting Link" section, the link should only be directing to

RHEA-AI

neutral

05/17/22 8:01 AM

Nasdaq : AEMD

conferences

Aethlon Medical to Present at the H.C. Wainwright Global Investment Conference

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, today announced that it will be presenting at the H.C. Wainwright Global Investment Conference. The

RHEA-AI

neutral

05/02/22 8:01 AM

Nasdaq : AEMD

covid-19

Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 Variants

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, today announced

RHEA-AI

neutral